title: High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus.
abstract: Ebolavirus, a member of the Filoviridae family of negative-sense RNA viruses, causes severe haemorrhagic fever leading up to 90% lethality. Ebolavirus matrix protein VP40 is involved in the virus assembly and budding process. The RNA binding pocket of VP40 is considered as the drug target site for structure based drug design. High Throughput Virtual Screening and molecular docking studies were employed to find the suitable inhibitors against VP40. Ten compounds showing good glide score and glide energy as well as interaction with specific amino acid residues were short listed as drug leads. These small molecule inhibitors could be potent inhibitors for VP40 matrix protein by blocking virus assembly and budding process.
authors.affiliation: Department of Bioinformatics, School of Bioengineering, Faculty of Engineering & Technology, SRM University, Kattankulathur, 603203, Tamil Nadu, India.
authors.forename: Thangaraju
authors.initials: T
authors.lastname: Tamilvanan
authors.forename: Waheeta
authors.initials: W
authors.lastname: Hopper
keywords: Ebolavirus; High throughput virtual screening; Molecular docking; VP40
references.citation: Vaccine. 2006 Apr 5;24(15):2975-86
references.pmid: 16530297
references.citation: Virology. 2001 Apr 25;283(1):1-6
references.pmid: 11312656
references.citation: J Infect Dis. 1999 Feb;179 Suppl 1:S224-34
references.pmid: 9988188
references.citation: Virology. 2001 Aug 1;286(2):384-90
references.pmid: 11485406
references.citation: J Virol. 2000 Sep;74(17):8127-34
references.pmid: 10933723
references.citation: Vaccine. 2001 Nov 12;20(3-4):586-93
references.pmid: 11672925
references.citation: EMBO J. 2000 Aug 15;19(16):4228-36
references.pmid: 10944105
references.citation: Virus Res. 2003 Apr;92(2):187-93
references.pmid: 12686428
references.citation: J Gen Virol. 1994 May;75 ( Pt 5):1031-42
references.pmid: 8176365
references.citation: Antiviral Res. 2003 Jan;57(1-2):53-60
references.pmid: 12615303
references.citation: J Virol. 2002 Apr;76(8):3952-64
references.pmid: 11907235
references.citation: Virology. 1998 Nov 10;251(1):28-37
references.pmid: 9813200
references.citation: J Virol. 1998 Oct;72(10):8413-9
references.pmid: 9733895
references.citation: Nature. 2000 Nov 30;408(6812):605-9
references.pmid: 11117750
references.citation: Structure. 2003 Apr;11(4):423-33
references.pmid: 12679020
references.citation: Antiviral Res. 2003 Mar;58(1):47-56
references.pmid: 12719006
references.citation: J Virol. 2001 Feb;75(3):1117-23
references.pmid: 11152484
references.citation: FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):27-31
references.pmid: 14734183
references.citation: PLoS Pathog. 2008 Nov;4(11):e1000212
references.pmid: 19023410
references.citation: J Mol Biol. 2000 Jun 30;300(1):103-12
references.pmid: 10864502
references.citation: J Virol. 2002 Sep;76(18):9176-85
references.pmid: 12186901
references.citation: Nucleic Acids Res. 2005 Jan 1;33(Database issue):D266-8
references.pmid: 15608193
references.citation: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
references.pmid: 11259830
references.citation: Vaccine. 2003 Sep 8;21(25-26):4071-80
references.pmid: 12922144
references.citation: Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6  No 1):899-907
references.pmid: 12037327
references.citation: J Exp Med. 2002 Mar 4;195(5):593-602
references.pmid: 11877482
references.citation: Virus Res. 1995 Dec;39(2-3):129-50
references.pmid: 8837880
references.citation: J Virol. 1991 Mar;65(3):1057-65
references.pmid: 1847435
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6
references.pmid: 11095724
references.citation: JAMA. 2002 May 8;287(18):2391-405
references.pmid: 11988060
references.citation: Antivir Chem Chemother. 2005;16(5):283-94
references.pmid: 16245644
references.citation: Vaccine. 2004 Sep 3;22(25-26):3495-502
references.pmid: 15308377
references.citation: Nat Med. 2001 Dec;7(12):1313-9
references.pmid: 11726971
references.citation: Antiviral Res. 2009 Sep;83(3):245-51
references.pmid: 19523489
references.citation: Nat Med. 2005 Jul;11(7):786-90
references.pmid: 15937495
references.citation: J Mol Biol. 2003 Feb 14;326(2):493-502
references.pmid: 12559917